- $1.00bn
- $789.02m
- $226.71m
- 98
- 21
- 25
- 45
Annual income statement for Vtex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 98.7 | 126 | 158 | 202 | 227 |
| Cost of Revenue | |||||
| Gross Profit | 63.8 | 76.2 | 105 | 141 | 167 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 92.2 | 192 | 208 | 216 | 217 |
| Operating Profit | 6.52 | -65.9 | -49.9 | -14.6 | 10.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.46 | -70 | -56.4 | -10.6 | 9.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.825 | -60.5 | -52.4 | -13.7 | 12 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.914 | -60.5 | -52.4 | -13.7 | 12 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.914 | -60.5 | -52.4 | -13.7 | 12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.005 | -0.333 | -0.275 | -0.073 | 0.062 |
| Dividends per Share |